Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways
about
Regulation of Dendritic Cell Function by Vitamin DSustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasisHumoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military PopulationsFunctional paralysis of GM-CSF-derived bone marrow cells productively infected with ectromelia virus.Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.Preclinical development of HIvax: Human survivin highly immunogenic vaccinesAutophagy proteins in antigen processing for presentation on MHC molecules.The elucidation of non-classical MHC class II antigen processing through the study of viral antigens.Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects.The localization of a heterologous displayed antigen in the baculovirus-budded virion determines the type and strength of induced adaptive immune response.HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells.Moving the Cellular Peptidome by Transporters.
P2860
Q26781521-C48CE0F7-788E-4454-A94F-4AEBCD32A743Q36069782-C0E13E70-485A-4C1A-BEDC-298A9C04C440Q36238314-28276CCA-66DD-4097-AF25-F43F031A6D76Q36399165-FA88725D-6133-49CF-95B9-69BE269F98A8Q38619090-54F9487C-793B-40FC-A553-B8EE6BF022D0Q38867680-6DA22512-1AC4-4211-A05E-69A64A1F2E4FQ38869705-9177164F-234F-4621-BA81-9C73E1F6CBAAQ39084138-2C3A7545-8310-4C48-8B26-64216786C90DQ40091454-511765A9-1619-4DF3-B888-60C56197B535Q40188529-CBC6E0A1-B5FC-4914-80FB-BB8CF574299FQ40329594-33154C21-81C0-4812-8E89-A73E6D5A5A62Q40706800-5D65CAAF-AA0B-4545-B07F-950111B9CCA5Q55365557-0714BAEB-A504-4DEF-AACB-3E2561A3AAA7
P2860
Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Modified vaccinia virus Ankara ...... class II presentation pathways
@ast
Modified vaccinia virus Ankara ...... class II presentation pathways
@en
type
label
Modified vaccinia virus Ankara ...... class II presentation pathways
@ast
Modified vaccinia virus Ankara ...... class II presentation pathways
@en
altLabel
Modified Vaccinia Virus Ankara ...... Class II Presentation Pathways
@en
prefLabel
Modified vaccinia virus Ankara ...... class II presentation pathways
@ast
Modified vaccinia virus Ankara ...... class II presentation pathways
@en
P2093
P2860
P356
P1433
P1476
Modified vaccinia virus Ankara ...... class II presentation pathways
@en
P2093
Frank Thiele
Ingo Drexler
Rubert Abele
Tina Zollmann
P2860
P304
P356
10.1128/JVI.03244-14
P407
P577
2014-12-17T00:00:00Z